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Trends inMarijuana Use Among Pregnant
andNonpregnant Reproductive-AgedWomen,
2002-2014
Between 2001 and 2013, marijuana use among US adults
more than doubled, many states legalized marijuana use,
and attitudes toward marijuana became more permissive.1
In aggregated 2007-2012
data,3.9%ofpregnantwomen
and 7.6% of nonpregnant
reproductive-aged women
reported past-month mari-
juana use.2 Although the evi-
dence ismixed, humanandanimal studies suggest that prena-
tal marijuana exposuremay be associated with poor offspring
outcomes (eg, lowbirthweight, impairedneurodevelopment).3
The American College of Obstetricians and Gynecologists rec-
ommends that pregnant women and women contemplating
pregnancy be screened for and discouraged from using mari-
juana and other substances.4 Whether marijuana use has
changed over time among pregnant and nonpregnant repro-
ductive-agedwomen is unknown.
Methods | The Columbia University Medical Center institu-
tional review board waived review of this study. Informed
oral consent was obtained from each participant. Data from
women aged 18 through 44 years from the annual National
Survey on Drug Use and Health (NSDUH) from 2002 through
2014 were analyzed. The surveys used in-person audio
computer-assisted self-interviews (ACASI) about substance
use and other behaviors in nationally representative samples
of the noninstitutionalized US population; average response
rates since 2002 were 75%.5 Among participants reporting
lifetime use of marijuana or hashish, recency of use was
assessed with the question: “How long has it been since you
last used marijuana or hashish?” Responses included “within
the past 30 days,” “more than 30 days ago but within the past
12 months,” and “more than 12 months ago.”5 Among preg-
nant and nonpregnant women, log-Poisson regression
(SUDAAN [RTI International], version 11.0.1) was used to esti-
mate and test trends in the adjusted prevalences of past-
month and past-year marijuana use over time, controlling for
complex survey design, age, race/ethnicity, family income,
and education. Differences in trends over time were exam-
ined by pregnancy status and age (18-25 years and 26-44
years). Results were considered statistically significant at
a P value of less than .05 (2-sided).
Results |Of the 200510women analyzed, 29.5%were aged 18
through 25 years and 70.5% were aged 26 through 44 years;
61.0%werewhite, 13.7%black, 17.2%Hispanic, and8.1%other
race/ethnicity; 59.2%had some college education; 55.9%had
annual family incomes less than$50000;and5.3%(n = 10587)
were pregnant.
Among all pregnant women, the adjusted prevalence of
past-month marijuana use increased from 2.37% (95% CI,
1.85%-3.04%) in 2002 to 3.85% (95% CI, 2.87%-5.18%) in
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Table. Trends in Prevalence ofMarijuana Use in Pregnant and NonpregnantWomen, 2002-2014a
Marijuana Use Among Women
Adjusted Prevalence, No. (%) [95% CI]b
Prevalence Ratio (95%
CI)e
P Value for Difference
in Prevalence Ratiosf2002 (n = 15 284)c 2014 (n = 15 318)d
Past monthg
.64Pregnant 40 (2.37) [1.85-3.04] 43 (3.85) [2.87-5.18] 1.62 (1.09-2.43)
Nonpregnant 1531 (6.29) [6.02-6.57] 1673 (9.27) [8.90-9.65] 1.47 (1.38-1.58)
Past year
.73Pregnant 134 (8.64) [7.32-10.19] 115 (11.63) [9.78-13.82] 1.35 (1.05-1.72)
Nonpregnant 2809 (12.37) [12.05-12.70] 2824 (15.93) [15.48-16.40] 1.29 (1.23-1.35)
a Data were from the US National Survey on Drug Use and Health (NSDUH).
bAdjusted prevalence estimates are from the linear predicted prevalencemodel
described in footnote a of the Figure.
c Sample sizes in 2002: pregnant women, n = 797; nonpregnant women,
n = 14 487.
d Sample sizes in 2014: pregnant women, n = 735: nonpregnant women,
n = 14 583.
e Prevalence ratios were the ratio of the adjusted prevalence estimates from
2014 divided by the adjusted prevalence estimates from 2002; ratios and 95%
CIs were from log-Poisson regressions. CIs for prevalence ratios that did not
include 1.00within the lower and upper levels indicated statistically significant
increasing trends in marijuana use.
f The test for difference in prevalence ratios was the P value of the
pregnancy × year interaction in the log-Poisson regression. This test indicated
whether the ratio of the prevalence ratios for pregnant vs nonpregnant
women differed significantly from 1.00. Nonsignificant P values (P  .05)
indicated insufficient evidence to conclude that the prevalence ratios differ.
g Past-monthmarijuana use was defined as responding “within the past 30
days” to the question, “How long has it been since you last usedmarijuana or
hashish?” Past-year marijuana use was defined as responses of “within the past
30 days” or “more than 30 days ago but within the past 12 months” to the
aforementioned question. Preprocessing of missing variables by predictive
mean neighborhood imputation and recoding was done prior to public release
of the NSDUH data sets.5 Because the analyses used the imputed variables of
NSDUH, there were nomissing data.
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2014 (prevalence ratio [PR], 1.62 [95% CI, 1.09-2.43])
(Table). The adjusted prevalence of past-month marijuana
use was highest among those aged 18 to 25 years, reaching
7.47% (95% CI, 4.67%-11.93%) in 2014 (Figure), significantly
higher (P = .02) than among those aged 26 to 44 years
(2.12% [95% CI, 0.74%-6.09%]). However, increases over
time did not differ by age (P = .76). Past-year use was higher
overall, reaching 11.63% (95% CI, 9.78%-13.82%) in 2014,
with similar trends over time.
In nonpregnant women, prevalences of past-month use
(2014:9.27%[95%CI, 8.90%-9.65%]) andpast-yearuse (2014:
15.93% [95% CI, 15.48%-16.40%]) were higher overall, with
similar trends over time. Increases over time in past-month
marijuana use did not differ by pregnancy status (P = .64).
Discussion | Among pregnant women, the prevalence of past-
month marijuana use increased 62% from 2002 through
2014. Prevalence was highest among women aged 18 to 25
years, indicating that young women are at greater risk for
prenatal marijuana use. Study limitations are noted. Self-
reported marijuana use may lead to underreporting due to
social desirability and recall biases. However, use of ACASI
helps reduce such biases,5 and the increases over time
observed in this study are consistent with increases over time
in marijuana-related outcomes shown in other studies that
did not rely on self-reports, supporting the validity of the
findings.6 Additionally, future studies should address dose,
frequency of use, and clinical outcomes.
These results offer an important step toward under-
standing trends in marijuana use among women of repro-
ductive age. Although the prevalence of past-month use
among pregnant women (3.85%) is not high, the increases
over time and potential adverse consequences of prenatal
marijuana exposure3 suggest further monitoring and
research are warranted. To ensure optimal maternal and
child health, practitioners should screen and counsel preg-
nant women and women contemplating pregnancy about
prenatal marijuana use.
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a Year-to-year–adjusted and linear predicted–adjusted prevalence estimates
were from log-Poisson regressions. Models controlled for race/ethnicity
(non-Hispanic white, non-Hispanic black, Hispanic, and other non-Hispanic
minorities), family income ($0-$19 999, $20000-$49999,
$50000-$74 999,$75000), age (18-25 years, 26-34 years, 35-44 years),
education (<high school, high school, some college), year (year was categorical
in the year-to-year model, and continuous in the linear predictedmodel),
pregnancy status, pregnancy × year interaction, covariate × pregnancy
interactions, and complex survey design. Error bars indicate 95% CIs and are
only shown for overall year-to-year–adjusted prevalence estimates.
Percentage of variability in dichotomousmarijuana use explained by the
model with year as a continuous variable was 6% (McFadden pseudo-R2);
the ratio of the pseudo-R2 statistics for themodels with year as a continuous
vs categorical variable was 0.98, indicating strong evidence for a linear trend.
b Past-monthmarijuana use was defined as responding “within the past
30 days” to the question, “How long has it been since you last usedmarijuana
or hashish?”
c Data were from the US National Survey on Drug Use and Health. Sample size
across all years combined: pregnant women (n = 10 587), nonpregnant
women (n = 189923).
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